John P. Veluchamy

512 total citations
9 papers, 399 citations indexed

About

John P. Veluchamy is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, John P. Veluchamy has authored 9 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 4 papers in Hematology. Recurrent topics in John P. Veluchamy's work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). John P. Veluchamy is often cited by papers focused on Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). John P. Veluchamy collaborates with scholars based in Netherlands, France and Germany. John P. Veluchamy's co-authors include Tanja D. de Gruijl, Hans van Vliet, Henk M.W. Verheul, Jan Spanholtz, Nina Kok, Daniëlle A.M. Heideman, Marleen Tordoir, Silvia Lopez‐Lastra, James P. Di Santo and Victor L. Thijssen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

John P. Veluchamy

8 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Veluchamy Netherlands 7 309 281 60 59 44 9 399
Dave Ankarlo United States 4 427 1.4× 226 0.8× 47 0.8× 63 1.1× 49 1.1× 4 491
Behiye Kodal United States 10 454 1.5× 399 1.4× 31 0.5× 55 0.9× 72 1.6× 18 535
Hilde Omholt Norway 6 579 1.9× 384 1.4× 52 0.9× 131 2.2× 44 1.0× 7 689
Juergen Kuball United States 3 281 0.9× 275 1.0× 32 0.5× 65 1.1× 13 0.3× 5 387
Erlend Strønen Norway 5 370 1.2× 339 1.2× 25 0.4× 148 2.5× 68 1.5× 7 463
F Triebel France 8 369 1.2× 197 0.7× 34 0.6× 54 0.9× 55 1.3× 11 435
Ilseyar Akhmetzyanova Germany 9 239 0.8× 150 0.5× 85 1.4× 94 1.6× 14 0.3× 10 381
Elshafa H. Ahmed United States 6 151 0.5× 155 0.6× 87 1.4× 70 1.2× 30 0.7× 14 275
Hongbo Wang United States 8 258 0.8× 154 0.5× 67 1.1× 46 0.8× 10 0.2× 11 311
Andres Wiernik United States 5 339 1.1× 278 1.0× 123 2.0× 58 1.0× 53 1.2× 8 461

Countries citing papers authored by John P. Veluchamy

Since Specialization
Citations

This map shows the geographic impact of John P. Veluchamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Veluchamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Veluchamy more than expected).

Fields of papers citing papers by John P. Veluchamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Veluchamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Veluchamy. The network helps show where John P. Veluchamy may publish in the future.

Co-authorship network of co-authors of John P. Veluchamy

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Veluchamy. A scholar is included among the top collaborators of John P. Veluchamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Veluchamy. John P. Veluchamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Veluchamy, John P.. (2020). An off the shelf, GMP compliant,fully closed and semi-automated large-scale production system for allogeneic NK cells. Cytotherapy. 22(5). S161–S162. 4 indexed citations
2.
Veluchamy, John P., Nina Kok, Hans van Vliet, et al.. (2017). The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments. Frontiers in Immunology. 8. 631–631. 148 indexed citations
3.
Veluchamy, John P., Silvia Lopez‐Lastra, Jan Spanholtz, et al.. (2017). In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer. Frontiers in Immunology. 8. 87–87. 38 indexed citations
4.
Veluchamy, John P., Nina Kok, Ruth Seggewiss‐Bernhardt, et al.. (2017). Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function. Scientific Reports. 7(1). 43873–43873. 21 indexed citations
5.
Bruin, Renée C.G. de, John P. Veluchamy, Sinéad M. Lougheed, et al.. (2017). A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells. OncoImmunology. 7(1). e1375641–e1375641. 68 indexed citations
6.
Veluchamy, John P., A. Marijne Heeren, Jan Spanholtz, et al.. (2016). High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status. Cancer Immunology Immunotherapy. 66(1). 51–61. 29 indexed citations
7.
Grimaldi, Francesco, Victoria Potter, John P. Veluchamy, et al.. (2016). Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells. Biology of Blood and Marrow Transplantation. 23(2). 293–299. 25 indexed citations
8.
Veluchamy, John P., Jan Spanholtz, Marleen Tordoir, et al.. (2016). Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer. PLoS ONE. 11(6). e0157830–e0157830. 66 indexed citations
9.
Veluchamy, John P., Jan Spanholtz, Nina Kok, et al.. (2016). Umbilical cord blood stem cell derived NK cells as universal treatment for metastatic colorectal cancer using EGFR independent killing mechanisms.. Journal of Clinical Oncology. 34(15_suppl). e14525–e14525.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dave Ankarlo Breakdown of academic impact, for papers by Behiye Kodal Breakdown of academic impact, for papers by Hilde Omholt Breakdown of academic impact, for papers by Juergen Kuball Breakdown of academic impact, for papers by Erlend Strønen Breakdown of academic impact, for papers by F Triebel Breakdown of academic impact, for papers by Ilseyar Akhmetzyanova Breakdown of academic impact, for papers by Elshafa H. Ahmed Breakdown of academic impact, for papers by Hongbo Wang Breakdown of academic impact, for papers by Andres Wiernik
Rankless by CCL
2026